Digital musculoskeletal care company SWORD Health has hired Dr. Vijay Yanamadala as chief medical officer. 

Yanamadala is a spinal neurosurgeon and currently serves as systemwide medical director of spine quality and surgical optimization at Hartford Healthcare in Connecticut.

"Similar to my clinical approach, SWORD meets patients where they are to provide solutions focused on strong outcomes. Offering non-surgical alternatives and effective solutions to members can help improve their health, eliminate their MSK pain and improve their quality of life overall. I’m thrilled to join SWORD and help the team to achieve a very valuable mission for the healthcare sector and for the world in general," Yanamadala said in a statement.

The digital MSK and physical therapy space drew plenty of investor interest last year. SWORD raised multiple rounds of funding in 2021, including $163 million in Series D funding plus a $26 million secondary round that bumped its valuation to $2 billion. 

Personal electrocardiogram maker AliveCor appointed Patricia Baran as senior vice president, healthcare Americas.

Baran will manage sales to employer, payer and health system clients. She most recently served as vice president of health systems for the central region at telehealth giant Teladoc Health, which she joined when it merged with chronic care management company Livongo. 

"Patti has made a broad impact across the health tech industry and will bring a fresh perspective to our teams during this pivotal time in our company's evolution," Vincent Balsamo, AliceCor's executive vice president of worldwide sales, said in a statement.

"As we continue to expand into new markets, Patti's experience launching integrated digital health solutions will be instrumental in achieving our long-term vision of providing end-to-end cardiac care for providers, payors, employers, and patients that extends well beyond our industry-leading devices."

Balsamo joined the company in December, alongside several new executive team hires from 2021. Earlier this month, AliveCor rolled out a credit card-sized personal ECG called KardiaMobile.

Socially Determined, which offers a platform that helps healthcare organizations find social and environmental issues affecting patient populations, announced two new hires to its executive team. 

Paul Matsui will serve as chief strategy officer, joining Socially Determined from the Advisory Board Company. He most recently worked as executive director of its data analytics research and technology business.

Mike Considine comes to the company from TransUnion, where he served as vice president of enterprise product initiatives for healthcare. He'll take over the role of chief product officer at Socially Determined.

"We’re at a point in the company’s trajectory where it’s time to sharpen our focus even more, scale our capabilities and bring what we’ve developed and learned to even more organizations who crave the insights we provide," the company's CEO and cofounder Dr. Trenor Williams said in a statement.

"I can’t think of two people better suited to help us achieve these goals than Paul and Mike. Their past experiences and accomplishments uniquely align with our mission to use social risk intelligence to improve business performance, clinical outcomes and health equity, and we’re ecstatic to have them on our team."

Virtual surgery platform Proximie has brought on Charlie H. Wilhelm as general manager for the Americas and Dave Herrmann as chief growth officer. 

Wilhelm comes to the company from KARL STORZ Endoscopy-America where he was president and COO. Herrmann previously served as global head of digital solutions for Johnson & Johnson Medtech.

"The proven track-records of Charlie and Dave bring a material value add to Proximie and will help us achieve our mission to create a future of truly connected surgical care. Charlie will be vital to our growth in the Americas, where we already have a considerable presence. Dave will play a key role in leading our partnership strategy and supporting our overall platform growth. They are the perfect additions at the perfect time," Proximie CEO and cofounder Dr. Nadine Hachach-Haram said in a statement.

In April, the company announced it had raised $38 million in Series B funding.